For Stakeholders Bidens Bid To Cut Drug Costs Is A Top Issue
Much of the reaction to President Joe Biden's State of the Union address concentrated on...
The UK Government Announces £260 Million To Fix Healthcare
The UK government has put forth its intention to invest £260 million in cutting-edge medical research...
Untreatable Lung Cancer Patients Get Breakthrough Treatment
The head of the NHS revealed today that a breakthrough targeted medication treating lung cancer...
Exclusive license for Croda to commercialise SSI’s CAF vaccine adjuvants
Croda International Plc, which uses smart science to improve lives, announces that it has entered...
AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio
AbbVie announced it has completed the acquisition of Syndesi Therapeutics SA, which will help to...
IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines
IDT Biologika, a leading Contract Development and Manufacturing Organization (CDMO) specialized in vaccines, gene and...
CTI Biopharma’s Drug For Bone Marrow Cancer Approved By FDA
The U.S. Food and Medication Administration authorised CTI BioPharma Corp's drug for treating adult patients...
INCOG Biopharma Services completes analytical and quality control testing laboratory & technology transfer suite
INCOG BioPharma Services announces it has completed the construction of its Quality Control testing laboratories,...
Biocon Biologics to Acquire Viatris Biosimilars Assets for up to USD 3.335 billion in...
Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has entered into a...
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA),...
Biohaven Pharmaceutical Holding Company Ltd. announced that it entered into a worldwide license agreement with...
